chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I felt hot and flushed right after the shot. It might have been adrenaline. I sat there for 30 minutes. Earlier that day: I was put under - I received another drug but I can't remember what it was. It is called an upper endoscopy. It was about 2-3 hours before I had the vaccine. I didn't have any symptoms that night except maybe a little anxiety/adrenaline. The next day, I started feeling like I was having a tightness in my chest. I was hungry for air. I have an oximeter - my oxygen was just fine - 100. My heart rate was accelerated even when I was sleeping - so I know it wasn't just anxiety. I had the feeling that I wasn't getting enough breath/hungry for air. But I kept wanting to breathe more even though oxygen was fine. My chest was tight and it was painful. I went to Health ER - they gave me a Decadron IV and IV Pepcid and something else. It helped almost immediately with my symptoms. I did pretty good for about three days - better than I had since before I had COVID in December. After those three days,  I started feeling back to my "normal" pre-vaccine symptoms from what I'd been having post COVID. I'm having the "long COVID" so I don't know if I'm recovered from vaccine but I think I was back to what I had before the vaccine.
I had a low-grade fever and chills. I had SOB, increased fatigue, changes in my taste and smell. I went to the ER.  I also have a pneumonia in both of my lower lungs that showed up on the CT scan.  They did a Covid-19 test, negative.  They did blood work and a urine sample, which show that I had a UTI.  I also had a kidney stone.   I also was having abdomen pain as well.
White blood cell count abnormal/White Blood Cell Count was 3.8; Red blood cell count abnormal/Red Blood Cell Count was 4.44; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of WHITE BLOOD CELL COUNT ABNORMAL (White blood cell count abnormal/White Blood Cell Count was 3.8), RED BLOOD CELL COUNT ABNORMAL (Red blood cell count abnormal/Red Blood Cell Count was 4.44) and COVID-19 (COVID-19) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products IBRUTINIB (IMBRUVICA) tablet for Chronic lymphocytic leukemia and IBRUTINIB (IMBRUVICA) for Chronic lymphocytic leukemia.    Concurrent medical conditions included Chronic lymphocytic leukemia.   On 22-Sep-2016, the patient started IBRUTINIB (IMBRUVICA) (Oral) at an unspecified dose. In 2022, the patient started IBRUTINIB (IMBRUVICA) (Oral) 420 milligram once a day. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2022, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced WHITE BLOOD CELL COUNT ABNORMAL (White blood cell count abnormal/White Blood Cell Count was 3.8) and RED BLOOD CELL COUNT ABNORMAL (Red blood cell count abnormal/Red Blood Cell Count was 4.44). The patient was treated with SOTROVIMAB at an unspecified dose and frequency. At the time of the report, WHITE BLOOD CELL COUNT ABNORMAL (White blood cell count abnormal/White Blood Cell Count was 3.8) and RED BLOOD CELL COUNT ABNORMAL (Red blood cell count abnormal/Red Blood Cell Count was 4.44) outcome was unknown and COVID-19 (COVID-19) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Feb-2022, SARS-CoV-2 test: COVID-19. On an unknown date, Glycosylated haemoglobin: 5.6. On an unknown date, Red blood cell count: 4.44. On an unknown date, White blood cell count: 3.8.   No concomitant medication details were provided.  The reporter's causality for the event of white blood cell count abnormal with IMBRUVICA(IBRUTINIB) tablet was a reasonable possibility and not provided for other events.  The reporter's causality for the events of white blood cell count abnormal, Red blood cell count abnormal and COVID-19 with IMBRUVICA(IBRUTINIB) was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Fever, sore red arm,  pulmonary embolism and a clot in my heart. Calcium and other labs are low or not in normal range
8 days after my first shot I got a large very itchy rash on my upper right arm.  Like poison ivy.   Cortisone cream did not work. Nothing has worked.  I received my 2nd shot yesterday and the itching is so bad.  I am taking 2 benadryl every 4 hours and using the cream but it's not helping.  My arm feels very hot this time also.
HSV2 positive for 13 years but rarely have a flair up even without acyclovir. Second vaccine dose triggered flair up the next day.
pt recv vax & devel small red dots on cheeks (face);no rash noted on any other part of body;rx DPH;pt broke out in little dots of blood all over face;dx rash d/t MMR:immun rxn;fine papular macular spots of erythema;
2/2  9:00 PM --2/6    soreness, slight swelling vaccine arm  2/3  -- 2/8  slight nausea, roiling gut, fatigue 2/10-- 2/12  intermittent slight fever & chills 2/10--  2/21  partial loss of sense of smell ongoing
Patient reported swelling and warmness at site of injection, with a bump under the skin.  Pharmacist recommended patient to call her Doctor or get medical treatment at Hospital Emergency Room.
First 20 hrs- He had extremely sore legs and arms even though vaccines were given only in arms.  He was achey and felt flu like.  Then had low grade temp- 99 orally.  After 24 hrs- he developed a headache, became dizzy and fever developed with feeling of falling while seated and aches in arms and legs persisted.  Vomiting started.  Called doc and told to bring him in if not better in a.m.  His fever climbed to 104 orally and fever treated with motrin which would bring it down to 101- 102 and then it would go back up.  He was unusually ill.  Around 40 hours after vaccines- he was getting better but still had temp of 101-102.  Treated with motrin and went to doctor.  Doctor did swab for flu and it was negative.  He came home and fever began to slowly come down. He began to keep food on stomach. Around 72 hours- he had recovered from all symptoms.
5cm induration and erythema at vaccine site. Tx with Ibuprofen and ice pack.
Patient complained shot was given too high and now has bursitis.  Patient is having trouble moving arm and problems with fine motor skills of hand.  His wife is planning on taking him to the doctor if symptoms persist.
12/4/12 - Numbness tingling in hands, feet, arms, legs. Dizziness, feeling faint. 12/13/12 ~9PM - same as above - reported to ER. Said it was myalgia. 12/17/12 ~7AM - reported to ER - sched appt w/Neurology for 12/18 said was paresthesia/numbness. Saw neuro - sd doesn't act like GBS.  12/18/12 2PM - saw Neurology - Sched EMG for 12/28/12. ~7 PM returned to ER this time couldn't move arms/legs. Kept overnight seen by Neuro again. Will return 12/28/12 for EMG. 12/26/12 again with numbness tingling hard to control movement of arms. Possibly will return to ER.
Localized bruising, pain, first at injection site, then inferior to the elbow. Limited range of motion. Bruising/pain resolved in about 10 days.   Narrative:
This case was reported by a physician via sales rep and described the occurrence of syncope in a 18-year-old male patient who received BEXSERO (batch number ABX766AA, expiry date July 2020) for prophylaxis. Co-suspect products included MENVEO for prophylaxis. The patient's past medical history included syncope (similar episode occurred on 7th April 2014) and sickness. On 19th November 2018, the patient received the 1st dose of BEXSERO .5 ml and MENVEO. On 19th November 2018, immediately after receiving BEXSERO and MENVEO, the patient experienced syncope (serious criteria GSK medically significant), dizziness, pallor, blood pressure decreased and pulse weak. The patient was treated with nutritional supplement nos (Pediasure) and citric acid + glucose + potassium phosphate monobasic + sodium chloride + sodium citrate + sucrose (Gatorade). On an unknown date, the outcome of the syncope was recovered/resolved and the outcome of the dizziness, pallor, blood pressure decreased and pulse weak were unknown. It was unknown if the reporter considered the syncope, dizziness, pallor, blood pressure decreased and pulse weak to be related to BEXSERO and MENVEO. Additional details were reported as follows: According to the physician, the patient visited to a physician because the patient was sick but no vaccine was administered at this visit. The patient received BEXSERO on the left arm. On 19th November 2018, the patient received MENVEO on the right arm. Almost immediately (like within 2 minutes) after vaccination, the patient experienced dizzy, face and lips were pale. The patient was lie down and this was all had in the office. The physician took pulses and noted they were weak but blood pressure was 110/70. So, the patient was observed and syncope resolved without further issue or medical intervention. On 19th November 2018 around 3:40 PM, the patient visited to a physician. The physician informed that, the patient had not anything to eat all day but drunk only Gatorade. The patient was left office at 4:40 pm with instructions from physician to eat something. On 20th December 2018, the patient received 2nd dose of BEXSERO without any incident. The reporter agreed upon follow up from GlaxoSmithKline.
Headache, neck pain, shooting pains throughout my body, joint pain in shoulders, arms, knees, and toes. Pain became chronic for six months and still linger. Also had muscle weakness in fingers, arms and legs with difficulty walking and performing daily activities. I went to my physician and a rheumatologist.
minor achiness; stiff; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (minor achiness) and MUSCULOSKELETAL STIFFNESS (stiff) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (minor achiness) and MUSCULOSKELETAL STIFFNESS (stiff). At the time of the report, PAIN (minor achiness) and MUSCULOSKELETAL STIFFNESS (stiff) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was reported.
wheezing,couldn't get breath;seen in ER & given bronchodilator by nebulizer,then discharged;following day had low grade fever & flu-like sx;
32 yo F with H of anaphylaxis to SMP/TMP, Pip/Tazo, PCN; multiple environmental allergies; Crohn's dx; asthma. Pt received 1st dose of Pfizer COVID vaccine on 4/1/21 and 10 minutes after her dose she felt her throat closing up, cough, SOB, and rash. Given benadryl, IM epi x2, IM solumedrol 125 mg, albuterol, and famotidine at vaccine center and transported to ED as this failed to help her symptoms. Pt received 5 rounds of IM epinephrine total (3x 0.01mg doses, 1x 0.3 mg dose, and 2 doses at vaccine center) with improvement in symptoms hours after her last dose of epi on night of admission. She was monitored overnight and given IV solumedrol x1 in the morning. Received PRN pepcid with resolution of rash;...
Patient is 17 years old and was administered an intradermal vaccine instead of recommended subcutaneous vaccine for people <18 years old
Mom notes several hours of unconsolable screaming within an hour of vaccines and about 12 hours of irritability, occasional staring and listlessness.
patient with difficulty breathing and difficulty swallowing. she presented to ED once, no distress but still feeling abnormal sensation. she was given steroids and potassium for low potassium and felt better. she returned a few hours later after she went to sleep and woke up with difficulty breathing and dysphagia again. this time her potassium and the rest of her blood work normalized, imaging was unimpressive and she was admitted for overnight observation. she was given benadryl, steroids and fluids the second time around.
Left thigh, edema, and reddness hot to touch. Painful to touch x 2 days was seen in ER. On Cefzil for 10 days.
This spontaneous report has been received from a physician via a company representative referring to a male patient of unknown age. Information about concurrent condition, concomitant medication and medical history was not provided. On an unknown date, an anonymous female was vaccinated with ZOSTAVAX 19400 plague forming unit(PFU), 19400 PFU single injection(lot number, expired date were not provided) subcutaneously. Two weeks later(date unspecified), the female patient's male spouse contracted shingles. The patient contact doctor's office for medical attention. The outcome of the shingles was not recovered. Additional information has been requested.
4 1/2 hours after the vaccination I experienced extreme pain in my upper body all the way through my neck 4 1/2 hours after the vaccination I experienced extreme pain in my upper body all the way through my neck. Then very tired. Around midnight I woke up with an excruciating headache fever chills. Was not able to go to work the following morning go to the headache and bodyaches all over with a stabbing pains in my side.  The following morning I woke up with red hives all over my body. The hive started at my neck and went down with my torso around my back and on the inner of my arms.   My headache has gone away but I still have the hives
Information has been received from a physician concerning a 15 month old male patient who in November 2010, was vaccinated with a dose of VARIVAX (Merck) (dose, route and Lot# not reported). The physician stated that on 07-FEB-2011 the patient experienced rash on his leg and would not walk shortly after receiving VARIVAX (Merck). Patient was given acyclovir as a treatment. At the time of the report the patient's outcome was unknown. The patient sought unspecified medical attention. Follow-up information was received from a licensed practical nurse concerning an 18 month old male patient (previously reported as 15 month old by physician) with "strep" at the time of vaccination who on 04-NOV-2010 was vaccinated with the first dose of VARIVAX (Merck (Lot # 667490/0784Z, expire date not reported), subcutaneously in the left thigh and with the first dose of MMR II (Lot # 667731/0647Z, expire date not reported), subcutaneously in the left thigh. Concomitant therapy included the fourth dose of DAPTACEL (lot # C3381AA, expire date not reported), intramuscularly in the right thigh and the first dose of FLUZONE (lot # LT3639AA, expire date not reported), intramuscularly in the right thigh, administered also on 04-NOV-2010. Licensed practical nurse stated that on 09-FEB-2011, the patient could not walk and developed blisters on his left thigh and his privates. The patient was diagnosed with shingles and treated with acyclovir 200/5 3.25 ml TID for 7 days. On 17-FEB-2011, they called to the patient's home to have him come in after training with vaccines. Licensed practical nurse stated that the site was dry with no scabs; so none was collected to try to get viral culture. On 17-FEB-2011, the patient recovered. The patient did not seek medical attention. Attention information is not expected.
I had pain in the injection area that I didn't think anything of but gradually got worst. It radiated down my arm, sometimes to my forearm. It was limiting my ability to do everyday things where I did not have full range of motion.
unfamiliar taste in mouth accompanied by excessive salivation within approx 5 minutes of shot, severe muscle weakness at injection site within approx 4 hours followed by severe muscle soreness/pain that gradually recovered over 2.5 days, fatigue/tiredness for 2 days, gastrointestinal upset and diarrhea starting within approximately 5 hours of shot and lasting approximately 5 days
12/30/2020 am started with local reaction of  swelling and pain in right arm along with heaviness of right arm.   Also extreme fatigue.  All of these sx subsided 01/02/2021.    12/30/2020 pm started with chills, assumed fever, achiness of arms and legs, nightmares, waking up in the middle of the night right sided headache.  All of these sx have subsided (12/31/2020) except for headache and waking up at night.  These two sx continue.
CDC reports: 3 mo infant had approx 1 minute apnea spell @ 36 hrs p/DTP/OPV immunization, fever, screaming episode & hypotonia.
sore arm; a little tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (a little tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (a little tired). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (a little tired) outcome was unknown.            No concomitant medication was provided by reporter. No treatment information was provided by reporter.   This case was linked to MOD-2021-372881, MOD-2021-372938 (Patient Link).
Patient stated she was hot and cold, and dizzy at 3:00pm. Called 911, patient refused to go to hospital. States she continued to have symptoms  of tremors, lower back pain, and fever through the night and went to urgent care. Released and states she is felling better as of 11:00 am 7/23/21.
doses administered after excursion; No adverse event; Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion), POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine) and NO ADVERSE EVENT (No adverse event) in an 80-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.   On 14-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Oct-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion), POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after excursion) and POOR QUALITY PRODUCT ADMINISTERED (Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable and patient received doses of the vaccine).    Concomitant medications details were not reported by the reporter.  Reportedly, Pharmacist called to discuss a temperature excursion that occurred several days ago in the freezer. the excursion was found out in an audit and all the vaccines were viable.  Treatment details were not reported by the reporter.
This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in left arm on 23Mar2021 at 09:00 (at the age of 29-years-old) as single dose for COVID-19 immunisation. The patients medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any other medication within 2 weeks of vaccination. On 23Mar2021 at 09:00, as the nurse was administering the vaccine, the needle separated from the syringe and the contents of the vaccine sprayed onto the patients arm and the nurse face shield. It could not be determined how much of the dose the patient received. The patient also experienced that the site of the injection was tender. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The therapeutic measures and treatment were not taken as a result of the events. The clinical outcome of incorrect dose administered, accidental exposure while administering the drug and vaccination site pain was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
his arm is still sore and swollen; his arm is still sore and swollen; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 18Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), PERIPHERAL SWELLING (non-serious), outcome "not recovered" and all described as "his arm is still sore and swollen".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
9/15/2018 - Within 6-7 hours after Shingles injection, begun feeling achy, weakened, distracted. Had fits of coldness, but not shivering. No fever present. Difficulty sleeping. 9/16/2018 - Aches presented more severely, more pronounced weakness, nausea. Could not perform daily activities. 9/17/2018 - Aches subsiding somewhat, weakness still present. Worked from home due to weakness. 9/18/2018 Aches diminished, weakness still present with some nausea. Working from home once more. Will hope these side effects leave as I am a very active guy: cycling, running, weights, and have not been this sick in many years. Have had flu vaccines for years (dosed same time different arm as SHINGRIX) and had 2016 Shingles vaccine with no side effects.
First vaccine was Moderna 2 Feb 21  at other location, now deployed to another state and unable to get 2nd moderna.   As per protocol, Jannsen vaccine given as above.  Tolerated without issues.